🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

KeyBanc maintains target on Phreesia shares ahead of earnings

EditorEmilio Ghigini
Published 05/24/2024, 09:30 AM
© Reuters.
PHR
-

On Friday, KeyBanc Capital Markets maintained its Overweight rating and a $30.00 price target on shares of Phreesia Inc . (NYSE: NYSE:PHR), a patient check-in and payments services provider. The firm's analyst highlighted positive proprietary data trends ahead of the company's upcoming earnings report.

Phreesia's first-quarter performance showed promising signs, with proprietary credit card data indicating a year-over-year increase of approximately 25% in payments to the company, and an approximate 27% rise month-to-date through May 19.

These trends suggest that payment revenues for Phreesia could surpass current consensus estimates for the quarter by nearly 10%. Historically, the firm's credit card data has demonstrated an 80% correlation with Phreesia's payment processing fees year-over-year.

The analyst also referred to a recent investor lunch with Phreesia's CFO, Balaji, which took place in mid-April. During the meeting, discussions about how Phreesia has been handling a cybersecurity issue affecting Change Healthcare (NASDAQ:CHNG) since mid-February were brought up.

Phreesia has been proactive in managing the situation by rerouting to other vendors to maintain uninterrupted operations.

Phreesia's next earnings report is scheduled for Thursday, May 30, after the market closes. Investors and analysts alike are keen to see whether the company's financial results will reflect the positive trends observed in the proprietary data.

The company's stock performance and investor sentiment leading up to the earnings release will likely be influenced by these expectations and the company's ability to effectively manage external challenges, such as cybersecurity issues.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.